Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

Case Report Investigates Possible Connection Between mRNA COVID-19 Vaccines and Cancer

February 12, 2026
Continue Reading
case-report-investigates-possible-connection-between-mrna-covid-19-vaccines-and-cancer
Posted inBiotechnology

New Diabetes Medication Shows Promise in Reducing Eye Disease Risk

February 12, 2026
Continue Reading
new-diabetes-medication-shows-promise-in-reducing-eye-disease-risk
Posted inBiotechnology

Impact of Activity on Older Adults’ Health and Falls

February 12, 2026
Continue Reading
impact-of-activity-on-older-adults’-health-and-falls
Posted inBiotechnology

Can Language Models Accurately Judge Empathy?

February 12, 2026
Continue Reading
can-language-models-accurately-judge-empathy?
Posted inBiotechnology

ASH Releases Clinical Practice Guidelines for Frontline and Relapsed/Refractory Management in Adolescents and Young Adults

February 12, 2026
Continue Reading
ash-releases-clinical-practice-guidelines-for-frontline-and-relapsed/refractory-management-in-adolescents-and-young-adults
Posted inBiotechnology

Cardiovascular Disease Models: Heart and Vasculature-on-a-Chip

February 12, 2026
Continue Reading
cardiovascular-disease-models:-heart-and-vasculature-on-a-chip
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

mechanisms-underlying-sjogren’s-disease-outlined-in-mice;-existing-drug-shows-therapeutic-promise
Posted inGenetics

Mechanisms Underlying Sjögren’s Disease Outlined in Mice; Existing Drug Shows Therapeutic Promise

December 19, 2024
Researchers at NYU College of Dentistry and NYU Grossman School of Medicine reported the findings of a study in mice…
Read More
how-fungi-make-a-promising-compound-for-treating-cancer-and-inflammation
Posted inGenetics

How Fungi Make a Promising Compound for Treating Cancer and Inflammation

December 18, 2024
The process by which fungi synthesize some of their most potent compounds has remained unclear for many years. This is…
Read More
xgen-venture-closes-$190m-fund-with-plans-to-invest-in-early-stage-biotech,-medtech-firms
Posted inBiotechnology

XGEN Venture closes $190M fund with plans to invest in early-stage biotech, medtech firms

December 18, 2024
Italian VC XGEN Venture has closed a 180 million euro ($190 million) fund for biotech and medtech companies. The life…
Read More
labcorp-launches-bird-flu-test-amid-first-severe-case-in-the-us
Posted inMedical Technology

Labcorp launches bird flu test amid first severe case in the US

December 18, 2024
Amid reports of the first severe human case of bird flu in the U.S., Labcorp has launched a molecular diagnostic…
Read More
the-state-of-cell-and-gene-therapy-2025
Posted inGenetics

The State of Cell and Gene Therapy 2025

December 18, 2024
Broadcast Date:  Wednesday, January 29, 2025Time:  8:00 am PT, 11:00 am ET, 17:00 CET The field of cell and gene…
Read More
alphabet-spinoff-sandboxaq-raises-$300m-fund-for-‘next-wave-of-ai’
Posted inBiotechnology

Alphabet spinoff SandboxAQ raises $300M fund for ‘next wave of AI’

December 18, 2024
Alphabet spinoff SandboxAQ has raised more than $300 million to go toward developing AI applications across multiple areas including drug…
Read More
lawsuit-accuses-applied-therapeutics-of-misleading-investors-before-fda-rejection
Posted inBiotechnology

Lawsuit accuses Applied Therapeutics of misleading investors before FDA rejection

December 18, 2024
After its rare disease drug was rejected by the FDA in late November, Applied Therapeutics vowed to fight on with…
Read More
editor’s-corner:-fierce-biotech’s-10-most-read-stories-of-2024
Posted inBiotechnology

Editor’s Corner: Fierce Biotech’s 10 most-read stories of 2024

December 18, 2024
For the end of this year, Fierce Biotech is taking the opportunity to reflect on trends emerging from 2024’s reporting.…
Read More
deep-learning-slashes-cell-line-development-time
Posted inGenetics

Deep Learning Slashes Cell Line Development Time

December 18, 2024
A biopharma company specializing in difficult-to-produce biologics has developed a deep learning model to rapidly predict protein expression using their…
Read More
optimizing-tff-for-mrna-filtration
Posted inGenetics

Optimizing TFF for mRNA Filtration

December 18, 2024
As steadily increasing numbers of mRNA vaccines and therapeutics advance through clinical trials and commercialization, the biopharmaceutical industry is pressed…
Read More

Posts pagination

Previous page 1 … 1,397 1,398 1,399 1,400 1,401 … 1,410 Next page
You May Have Missed
ge-healthcare-debuts-tech-to-help-hospitals-remotely-maintain-bedside-ecg-stations
Posted inMedical Technology

GE HealthCare debuts tech to help hospitals remotely maintain bedside ECG stations

merck-teams-up-with-british-medtech-to-boost-vaginal-therapeutics-delivery-system
Posted inMedical Technology

Merck teams up with British medtech to boost vaginal therapeutics delivery system

fda-slaps-highest-risk-recall-notice-on-j&j-medtech-cerepak-detachable-coils
Posted inMedical Technology

FDA slaps highest-risk recall notice on J&J Medtech Cerepak detachable coils

qiagen-‘open-for-discussion’-on-shareholder-value,-but-ceo-stays-mum-on-takeover-talk
Posted inMedical Technology

Qiagen ‘open for discussion’ on shareholder value, but CEO stays mum on takeover talk

Privacy Policy    Terms

Scroll to Top